Atlas Trials

Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes

Clinical trial NCT05174507 · WITHDRAWN

Trial details

NCT number
NCT05174507
Sponsor
University Hospital, Basel, Switzerland
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Postprandial Hypoglycemia
Start date
2022-06-24
Primary completion
2026-05-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.